Seth Klarman's position in Jazz Pharmaceuticals plc is currently worth $87.2 Million. That's 1.68% of their equity portfolio (16th largest holding). The investor owns 1.05% of the outstanding Jazz Pharmaceuticals plc stock. The investor's estimated purchase price is $97 Million, resulting in a loss of 10%.